Grigory G. Borisenko

Grigory G. Borisenko, Ph.D. is the Investment Director of RUSNANO Management Company LLC, venture capital & private equity management company in Russia. Dr. Borisenko has over 20 years of scientific, management, and strategic experience in the life sciences field, and has specialized in investment projects in life sciences since 2012. From 2009 through 2012, he served as head of the pharmaceutical sector of the Department of Science and Technology Expertise at the state corporation, RUSNANO. Dr. Borisenko currently serves on the Board of Directors of two biotechnology companies, Atea Pharmaceuticals, Inc. and Adastra Pharmaceuticals, Inc., and from 2011 to 2014, served on the Board of Directors of Nearmedic Pharm LLC. Prior to his investment career, Dr. Borisenko held academic appointments with the University of Pittsburgh, Russian State Medical University, and the Institute of Medico-Biological Problems. He has co-authored over 50 peer-reviewed publications in leading biochemistry and cell biology journals. Dr. Borisenko received his M.S. and Ph.D. from the Russian State Medical University and is a recipient of Fogarty International and International Fellowship Awards from NIH.